CSF hyperdynamics in rats mimicking the obesity and androgen excess characteristic of patients with idiopathic intracranial hypertension.

Journal Information

Full Title: Fluids Barriers CNS

Abbreviation: Fluids Barriers CNS

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Neurology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
5/6
83.3% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Evidence found in paper:

"raw data are available at the national center for biotechnology information (ncbi) gene expression omnibus (geo) database (gse232814).; raw rnaseq data are available at the ncbi geo database with accession number gse232814 https://www ncbi nlm nih gov/geo/query/acc cgi? scripts and data analysis are available at: https://github com/sorennorge/macaulaylab-rnaseq3-zucker . data availability the datasets used in the current study are available from the corresponding author on reasonable request. raw rnaseq data are available at the ncbi geo database with accession number gse232814"

Evidence found in paper:

"all program parameter settings for library building and mapping together with all scripts for the gene annotation and analysis are available at https://github com/sorennorge/macaulaylab-rnaseq3-zucker .; scripts and data analysis are available at: https://github com/sorennorge/macaulaylab-rnaseq3-zucker ."

Evidence found in paper:

"Declarations Ethics approvalAnimal experiments were in compliance with the European Community Council Directive 2010/63/EU on the Protection of Animals used for Scientific Purposes. It was approved by the Danish Animal Experiments Inspectorate with permission no. 2018-15-0201-01515. Consent for publicationNot applicable. Competing interestsAJS reports consulting fees and stockholding with Invex therapeutics, during the conduct of the study, she has also received personal fees for advisory board and lectures from Allergan, Amgen, Novartis and Cheisi on topics unrelated to the submitted work. The remaining authors declare that they have no competing interests. Competing interests AJS reports consulting fees and stockholding with Invex therapeutics, during the conduct of the study, she has also received personal fees for advisory board and lectures from Allergan, Amgen, Novartis and Cheisi on topics unrelated to the submitted work. The remaining authors declare that they have no competing interests."

Evidence found in paper:

"Funding Open access funding provided by Copenhagen University. This project was funded by the Lundbeck Foundation (R276-2018-403 to NM, R303-2018-3005 to TLTB), the Carlsberg Foundation (CF19-0056 to NM) and by Sir Jules Thorn Award for Biomedical Science (AJS). Open access funding provided by Copenhagen University"

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025